EKLF/KLF1 is an essential transcription factor that plays a global role in erythroid transcriptional activation. It's own regulation is of interest, as it displays a highly restricted expression pattern, limited to erythroid cells and its progenitors. Here we use biochemical affinity purification to identify the Ddx5/p68 protein as a potential activator of KLF1 by virtue of its interaction with the erythroid-specific DNAse hypersensitive site (EHS1) upstream enhancer element. We postulate that its range of interactions with other proteins known to interact with this element render it part of the enhanseosome complex critical for optimal expression of KLF1.
Introduction
The mechanisms by which intracellular transcriptional regulators interact to direct hematopoietic stem cells towards a particular lineage and exert control in target expression remains a major question in cellular and molecular studies (Hewitt et al., 2014; Novershtern et al., 2011; Xu et al., 2012) . Analysis of the erythroid lineage has led to the successful characterization of regulators that act as transcription factors and establish the proper network to generate erythroid-specific expression. However, in many cases it remains unresolved how these factors are themselves regulated One way to address these issues is to isolate genomic clones that code for the gene-specific regulators and determine their own cis-acting regulatory elements and the trans-acting factors that bind to them. Based on this notion, we have been studying the regulation of erythroid Krüppel-like factor (EKLF;KLF1 (Miller and Bieker, 1993) ), an erythroid-enriched transcription factor that is intimately involved in global regulation of downstream erythroid-specific gene expression by binding to cognate CCMCRCCCN elements (Siatecka and Bieker, 2011; Tallack and Perkins, 2010; Yien and Bieker, 2013) . A number of functional properties and expression characteristics of KLF1 make it of interest to study its regulation.
First, KLF1 expression remains tissue-specific throughout early development and in the adult.
Its onset is strictly limited to the mesodermal, primitive erythroid cells that populate the blood islands of the extraembryonic yolk sac at the early headfold stage (E7.5), switching by E9.5 to definitive cells within the hepatic primordia, and then to the red pulp of the adult spleen (Southwood et al., 1996) .
KLF1 is expressed at low levels in the MPP early in hematopoietic differentiation and it retains an expression pattern restricted to the CMP and MEP as its transcript levels increase prior to eventual segregation to erythroid progeny (Cui et al., 2009; Frontelo et al., 2007; Li et al., 2012) .
Second, KLF1's activation target repertoire has expanded beyond the classical ß-globin gene to include protein-stabilizing, heme biosynthetic pathway, red cell membrane protein, cell cycle, and transcription factor genes in both primitive and definitive erythroid cells (Gnanapragasam and Bieker, 2017; Siatecka and Bieker, 2011; Tallack and Perkins, 2010; Yien and Bieker, 2013) . Relatedly, links have been established between mutant or haploinsufficient levels of KLF1 and altered human hematology and anemia (Siatecka and Bieker, 2011; Singleton et al., 2012; Tallack and Perkins, 2013) , as some genes are uniquely sensitive to haploinsufficient levels of KLF1 (Perkins et al., 2016; Waye and Eng, 2015) .
We have shown that a 950 base pair region, located just upstream of the KLF1 transcription initiation site, is sufficient to generate erythroid-specific expression in transient assays (Chen et al., 1998) . This region exhibits the most significant homology upon a seven species alignment of 30 kB of surrounding genomic DNA (Lohmann and Bieker, 2008) , and harbors erythroid-restricted DNAse hypersensitive sites. One of these sites (EHS1) behaves as a very strong enhancer, which in conjunction with the proximal promoter (Anderson et al., 1998 (Anderson et al., , 2000 Crossley et al., 1994) accounts for KLF1's tissue-specific expression (Chen et al., 1998) . The importance of this short region has been verified in vivo (Adelman et al., 2002; Xue et al., 2004; Zhou et al., 2010) . We have suggested a twotiered mechanism for transcriptional regulation of KLF1, with GATA2 and SMAD5 proteins initially generating low transcript levels, followed by high quantities of KLF1 transcript after GATA1 protein is produced (Lohmann and Bieker, 2008) . Coupled to our recent inclusion of the DEK protein into this complex along with erythroid histone marks (Lohmann et al., 2015) , EHS1 can now be considered a well-characterized erythroid enhancer.
Our identification of DEK relied on a biochemical affinity purification to a region of EHS1 denoted as 'oligo2' region of EHS1 (Lohmann et al., 2015) . In the present study, we have identified a second protein that also binds to that region.
Materials and Methods
32DEpo1 cells were grown as previously described (Chen et al., 1998) . EHS1-binding proteins were purified as previously described (Lohmann et al., 2015) , focused on 'oligo2' (Chen et al., 1998) . Briefly, M280 magnetic Dynabeads coupled with streptavidin (Life Technologies) were incubated with biotinylated oligo2 to create the oligo Dynabeads. The 32DEpo1 cell lysate (Chen et al., 1998) was added and incubation continued at room temperature with rotation. Using a magnetic apparatus, the beads were washed to remove most of the non-specific binding proteins before elution in high salt. Eluted protein was dialyzed and concentrated by acetone precipitation prior to SDS-PAGE electrophoresis. Proteins were visualized by staining with colloidal blue and bands of interest were excised. Mass spec analyses of the gel slices were performed by the Rockefeller University Protein and DNA Technology Center using the Sonar MS/MS search engine coupled with statistical scoring methods (Field et al., 2002) .
Databases used as part of this study include transcription factor (Pilon et al., 2011; Stamatoyannopoulos et al., 2012) , and erythroid expression (Kingsley et al., 2013) sources.
Results
We had utilized a magnetic bead approach based on DNA affinity technology, coupled with mass spec analysis of the selected, associated proteins, to isolate proteins that bind the "oligo2" sequence within EHS1. This enabled identification of the "35kD" protein as DEK (Lohmann et al., 2015) . We next focused our attention on the oligo2-enriched protein at ~60kD. MALDI/TOF isolation of peptides and their sequence analysis yielded a particularly significant hit with the p68/Ddx5 protein ( Figure 1 ).
There is a considerable literature on this protein and its interactions with nucleic acids (Fuller-Pace, 2006 , 2013 . Ddx5 is a generally expressed 'DEAD box' family protein that interacts with DNA via chromatin, and plays a role in a range of RNA processing complexes. Ddx5 contains an ATPdependent RNA helicase activity that is an important part of the Drosha complex (Davis et al., 2008; Fukuda et al., 2007) , although evidence suggests that this activity is dispensable for its transcriptional regulatory function (Fuller-Pace, 2006 , 2013 . Disruption leads to mouse embryonic lethality by E11.5 (Fukuda et al., 2007) . Ddx5's role at specific mammalian promoters has been primarily analyzed in conjunction with the ERα where it acts as a coactivator (Metivier et al., 2003) , a function it also performs with p53, particularly at the p21 promoter (Bates et al., 2005; Nicol et al., 2013) . Ddx5 acts as a barrier to reprogramming of somatic cells to pluripotency (Li et al., 2017) , and its phosphorylation by c-Abl kinase plays a role in epithelial/mesenchymal transition (Yang et al., 2006) .
Ddx5 is well expressed within erythroid cells at all stages of differentiation, and in progenitors ( Figure 2 ). One interesting aspect in this case (compared to DEK) is that there is no evidence that p68/Ddx5 interacts with a specific DNA sequence.
Of relevance to KLF1 regulation, Ddx5 interacts with P300 and CBP (Rossow and Janknecht, 2003) , and is part of a hematopoietic cell complex that forms with Scl/Tal1 (Schuh et al., 2005) , a protein already known to interact with the KLF1 EHS1 region (Su et al., 2013; Wontakal et al., 2012) .
Ddx5 also interacts with Smad5 (Davis et al., 2008; Warner et al., 2004) , a protein we and others have shown is critical for KLF1 induction (Lohmann and Bieker, 2008; Perna et al., 2015) . As a result, it is relatively straightforward to envision this protein's role in KLF1 transcriptional activation via EHS1 ( Figure 3 ).
Discussion
We have identified p68/Ddx5 as the other unique/novel protein that interacts with the 'oligo2' region of EHS1. Given that both DEK and Ddx5 were isolated from the same preparation, this suggests that they may in fact interact.
An interesting aspect is that Ddx5 performs much of its function via the long noncoding (lnc) RNA molecule SRA (Caretti et al., 2007; Watanabe et al., 2001) , although a separate interaction with lncRNA Rmrp in T cells has also been described (Huang et al., 2015) . The importance of the Ddx5/SRA interaction for transcriptional activation has been established during muscle differentiation (Caretti et al., 2006) and in insulator control of gene expression (Yao et al., 2010) . Ddx5 interacts with myoD, and plays a necessary role in skeletal muscle differentiation, in part by complexing with and stabilizing the activating myoD/Brg1 interaction and aiding the recruitment of TBP and RNA pol II to muscle gene promoters (Caretti et al., 2006) . Some splice variants of SRA code for the protein SRAP Leedman, 2009, 2011; Lanz et al., 1999) . At the present time, SRA has not been implicated in erythroid cell regulation.
Ddx5 also interacts with CTCF (Yao et al., 2010) , a protein that plays a critical role in a range of functions including higher order chromatin structure and enhancer insulation (Phillips and Corces, 2009; Rao et al., 2014; Wallace and Felsenfeld, 2007) . RNA pull-down of SRA recovers Ddx5 and CTCF in a complex (Wongtrakoongate et al., 2015) . CTCF is already a well-known player in erythroid gene regulation, as it is required for proper looping at the ß-globin, SCL/TAL1, and myb transcription units (Hou et al., 2008; Lee et al., 2017; Splinter et al., 2006; Stadhouders et al., 2012; Zhou et al., 2013) . These long-range interactions that involve CTCF (and likely cohesin (Hou et al., 2010) ) can play a direct role in coupling tissue-restricted enhancement with a block in ectopic expression, such as that observed at the SCL/TAL1 locus (Patel et al., 2014) .
Based on these properties, we hypothesize that Ddx5, in a complex with other proteins at EHS1 (Figure 3) , plays a directive role in establishing a 3-dimensional structure at the KLF1 genomic locus via an interaction with CTCF. Perusal of genome browser data show that CTCF interacts within the KLF1 gene body (not shown), lending support to this general notion. Figure 1 . Analysis of affinity-purified proteins. DNA binding proteins that interact with oligo2 were monitored by SDS/PAGE analysis of 35 S methionine-labeled proteins after oligo1 or oligo2 affinity purification. Purified material derived from ~5X10E6 cell equivalents are shown. Arrowhead on right marks the protein unique to oligo 2 preparation that is the focus of this study, along with the mass spec data (Sonar MS/MS analysis: a:b:y ratio is of the fragmentation ions; z m/z m-a is the charge mass/charge measured minus calculated mass; the vertical bar between amino acid pairs indicates the ion intensity within the peptide fragment (Field et al., 2002) ) and peptide sequences used in its identification; lines on left indicate molecular weight as indicated (kD). (Lohmann and Bieker, 2008; Lohmann et al., 2015) . Blocks of conserved sequence homology between seven mammalian species are color-coded for their transcription factor binding sites, highlighting Smad, DEK, Gata-Ebox-Gata sites; location of oligo2 used in this study (based on (Chen et al., 1998) ) is as indicated.
Figure legends
Also drawn in are schematics of potential enhanceosome components at EHS1: Above includes the known multicomponent Gata/Tal1/Lmo2/Ldb1 multi-protein complex (based on (Deng et al., 2012; Li et al., 2013; Su et al., 2013; Ulirsch et al., 2014; Xu et al., 2012) ); below brings in known Ddx5 protein interactions as discussed in the text. DNA binding proteins that interact with oligo2 were monitored by SDS/PAGE analysis of 35 S methionine-labeled proteins after oligo1 or oligo2 affinity purification. Purified material derived from ~5X10E6 cell equivalents are shown. Arrowhead on right marks the protein unique to oligo 2 preparation that is the focus of this study, along with the mass spec data (Sonar MS/MS analysis: a:b:y ratio is of the fragmentation ions; z m/z m-a is the charge mass/charge measured minus calculated mass; the vertical bar between amino acid pairs indicates the ion intensity within the peptide fragment (Field et al., 2002) ) and peptide sequences used in its identification; lines on left indicate molecular weight as indicated (kD). (Lohmann and Bieker, 2008; Lohmann et al., 2015) . Blocks of conserved sequence homology between seven mammalian species are color-coded for their transcription factor binding sites, highlighting Smad, DEK, Gata-Ebox-Gata sites; location of oligo2 used in this study (based on (Chen et al., 1998) ) is as indicated.
Also drawn in are schematics of potential enhanceosome components at EHS1: Above includes the known multicomponent Gata/Tal1/Lmo2/Ldb1 multi-protein complex (based on (Deng et al., 2012; Li et al., 2013; Su et al., 2013; Ulirsch et al., 2014; Xu et al., 2012) ); below brings in known Ddx5 protein interactions as discussed in the text.
